A detailed history of Susquehanna Fundamental Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 972,243 shares of BMY stock, worth $56 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
972,243
Holding current value
$56 Million
% of portfolio
0.93%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$40.25 - $52.99 $39.1 Million - $51.5 Million
972,243 New
972,243 $40.4 Billion
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $801 - $473,564
6,163 New
6,163 $438,000
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $6.83 Million - $7.74 Million
-118,340 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $6.8 Million - $7.53 Million
118,340 New
118,340 $7.14 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $4.63 Million - $5.41 Million
-84,400 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $2.2 Million - $3.2 Million
47,400 Added 128.11%
84,400 $4.7 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $127,946 - $166,894
2,600 Added 7.56%
37,000 $2.38 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $5.25 Million - $6.22 Million
-122,700 Reduced 78.1%
34,400 $1.74 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $1.53 Million - $1.7 Million
34,400 Added 28.04%
157,100 $7.12 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $5.54 Million - $6.6 Million
122,700 New
122,700 $5.85 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $3.44 Million - $4.28 Million
-68,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $4.07 Million - $4.69 Million
68,000 New
68,000 $4.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.